Seto Bio

Company Deals

Insilico Medicine and Seto Biopartner to Leverage AI in Synthetic Biology and Drug Discovery

Fineline Cube Oct 8, 2024

Insilico Medicine has announced a strategic partnership with Seto Bio (SHE: 300583) to harness cutting-edge...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod